A Study of GTAEXS617 in People With Solid Tumor Cancer

Full Title

A Phase 1/2 Open-Label Multicenter Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of GTAEXS617 in Patients with Advanced Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Julia Blanter’s office at 646-888-4412.

Protocol
26-157
Phase
Phase I/II (phases 1 and 2 combined)
Investigator
Julia Blanter
Co-Investigators
Roisin E. O'Cearbhaill
Diseases
Breast Cancer
Gynecologic Cancer › Ovarian Cancer
Hepatobiliary › Pancreatic Cancer
Lung Cancer › Lung Cancer, Non-Small Cell
Lung Cancer, Non-Small Cell › Lung Adenocarcinoma
Squamous Cell Carcinoma
Upper Gastrointestinal › Pancreatic Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT05985655
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description